-transparent.png){kind=logo}
The injection of various doses of morphine, subcutaneously, or of beta-endorphin, intraventricularly, changes the turnover rate of gamma-aminobutyric acid (TRGABA) in the substantia nigra, globus pallidus and nucleus caudatus. The TRGABA decreases in N. caudatus but increases in globus pallidus and substantia nigra. These changes are dose related and can be inhibited by naltrexone. The increased TRGABA in globus pallidus elicited by these opioid receptor agonists may be associated with catalepsy since muscimol, a specific GABA receptor agonist, injected into the globus pallidus causes a dose-related catalepsy. Since this GABA receptor agonist injected into the substantia nigra fails to cause catalepsy, one can exclude that the increase in the TRGABA of substantia nigra elicited by opiate receptor agonists is operative in mediating the catalepsy elicited by opioids.
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
August 1977,
Brain research,
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
August 1978,
Neuropharmacology,
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
January 1978,
Experientia,
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
January 2008,
Stereotactic and functional neurosurgery,
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
October 1986,
Neuroscience letters,
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
May 1980,
Brain research,
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
June 1994,
Brain research,
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
January 1977,
Advances in biochemical psychopharmacology,
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
August 1980,
The Journal of comparative neurology,
F Moroni, and
D L Cheney, and
E Peralta, and
E Costa
January 1974,
Confinia neurologica,
